CRISPR, Gene-Based Therapeutics, and Clinical Trials

The Interface of Discovery and Clinical Development

This is the first paper in a series on CRISPR technology that explores domains relevant to professional staff accountable for the design in the implementation of strategic clinical development programs involving advanced therapy medicinal products (ATMPS), beginning with translational medicine to the interface of discovery with development. Read our white paper to learn more.

Your form has been successfully submitted! Click the button below to access.